Assignee
BASILEA PHARM INT AG
CH·6 granted patents·7 pending applications·2 citations·filing 2016–2020
Top patents by PatentIndex Score
13 records- 0176US11891382B2Processes for the preparation of furazanobenzimidazoles and crystalline forms thereofBASILEA PHARM INT AG·Filed 2018·Granted Feb 6, 2024·2 cites·32 claims
- 0256US2020115339A1Efflux-pump inhibitors and therapeutic uses thereofBASILEA PHARM INT AG·Filed 2019·Application pending·0 cites
- 0351US2022370418A1Pharmaceutical combinations comprising a furazanobenzimidazoles and a cd40 agonist for use in the treatment of neoplastic diseasesBASILEA PHARM INT AG·Filed 2020·Application pending·0 cites
- 0449US10464896B2Efflux-pump inhibitors and therapeutic uses thereofBASILEA PHARM INT AG·Filed 2016·Granted Nov 5, 2019·0 cites·48 claims
- 0545US2020031811A1Substituted mono- and polyazanaphthalene derivatives and their useBASILEA PHARM INT AG·Filed 2019·Application pending·0 cites
- 0642US2022402900A11,2,4-oxadiazol-5-one derivatives for the treatment of cancerBASILEA PHARM INT AG·Filed 2020·Application pending·0 cites
- 0741US12428414B2Methods for purifying isavuconazonium sulfateBASILEA PHARM INT AG·Filed 2019·Granted Sep 30, 2025·0 cites·29 claims
- 0838US11633383B2Dosage principle for drugs useful for treating neoplastic diseasesBASILEA PHARM INT AG·Filed 2018·Granted Apr 25, 2023·0 cites·52 claims
- 0938US2022031670A1Pharmaceutical combinations for use in the treatment of neoplastic diseasesBASILEA PHARM INT AG·Filed 2019·Application pending·0 cites
- 1037US11419856B2Pharmaceutical combinations for use in the treatment of neoplastic diseasesBASILEA PHARM INT AG·Filed 2018·Granted Aug 23, 2022·0 cites·32 claims
- 1137US10487075B2Substituted mono- and polyazanaphthalene derivatives and their useBASILEA PHARM INT AG·Filed 2016·Granted Nov 26, 2019·0 cites·41 claims
- 1233US2018306790A1Use of eb1 as a biomarker of drug responseBASILEA PHARM INT AG·Filed 2016·Application pending·0 cites
- 1328US2019142810A1Mitochondrial inhibitors for the treatment of proliferation disordersBASILEA PHARM INT AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BASILEA PHARM INT AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →